Similar articles for PMID: 20846830

Year	Number of Results
1951	1
1977	1
1981	1
1982	2
1983	1
1991	1
1992	1
1996	1
1997	2
1998	2
1999	2
2000	3
2001	4
2002	5
2003	6
2004	5
2005	2
2006	12
2007	8
2008	22
2009	15
2010	25
2011	14
2012	14
2013	19
2014	14
2015	18
2016	20
2017	10
2018	9
2019	10
2020	9
2021	5
2022	3
2024	0

1

In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).

Saravolatz LD, Pawlak J, Johnson LB, Saravolatz LD 2nd, Husain N. Saravolatz LD, et al. Int J Antimicrob Agents. 2010 Nov;36(5):478-80. doi: 10.1016/j.ijantimicag.2010.07.016. Epub 2010 Sep 16. Int J Antimicrob Agents. 2010. PMID: 20846830 No abstract available.

2

In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).

Saravolatz LD, Pawlak J, Johnson LB. Saravolatz LD, et al. Int J Antimicrob Agents. 2010 Jul;36(1):69-72. doi: 10.1016/j.ijantimicag.2010.02.023. Epub 2010 Apr 21. Int J Antimicrob Agents. 2010. PMID: 20413274

3

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.

Zhanel GG, Voth D, Nichol K, Karlowsky JA, Noreddin AM, Hoban DJ. Zhanel GG, et al. J Antimicrob Chemother. 2009 Aug;64(2):364-9. doi: 10.1093/jac/dkp176. Epub 2009 May 19. J Antimicrob Chemother. 2009. PMID: 19454524

4

In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.

Denis O, Deplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R, De Mendonça R, Struelens MJ. Denis O, et al. Antimicrob Agents Chemother. 2006 Aug;50(8):2680-5. doi: 10.1128/AAC.00272-06. Antimicrob Agents Chemother. 2006. PMID: 16870758 Free PMC article.

5

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK. Marty FM, et al. J Clin Microbiol. 2006 Feb;44(2):595-7. doi: 10.1128/JCM.44.2.595-597.2006. J Clin Microbiol. 2006. PMID: 16455920 Free PMC article.

6

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.

Kelley PG, Gao W, Ward PB, Howden BP. Kelley PG, et al. J Antimicrob Chemother. 2011 May;66(5):1057-60. doi: 10.1093/jac/dkr066. Epub 2011 Mar 2. J Antimicrob Chemother. 2011. PMID: 21393156

7

In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.

Saravolatz LD, Pawlak J, Johnson LB. Saravolatz LD, et al. Clin Infect Dis. 2012 Aug;55(4):582-6. doi: 10.1093/cid/cis492. Epub 2012 May 21. Clin Infect Dis. 2012. PMID: 22615331

8

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.

Farrell DJ, Flamm RK, Sader HS, Jones RN. Farrell DJ, et al. Int J Antimicrob Agents. 2014 Apr;43(4):323-7. doi: 10.1016/j.ijantimicag.2013.11.005. Epub 2013 Dec 11. Int J Antimicrob Agents. 2014. PMID: 24411474

9

Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.

Appleman MD, Citron DM. Appleman MD, et al. Diagn Microbiol Infect Dis. 2010 Apr;66(4):441-4. doi: 10.1016/j.diagmicrobio.2009.11.008. Diagn Microbiol Infect Dis. 2010. PMID: 20226335

10

Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.

Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR. Huang YT, et al. J Clin Microbiol. 2008 Mar;46(3):1132-6. doi: 10.1128/JCM.01844-07. Epub 2008 Jan 16. J Clin Microbiol. 2008. PMID: 18199793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

241 results

Results by year